Overview
Kasabach-Merritt syndrome (KMS) is characterized by severe thrombocytopenia associated with large, locally infiltrative hemangiomas, often leading to life-threatening bleeding and coagulopathy 13.Diagnosis
Clinical Presentation: Severe thrombocytopenia, large hemangiomas, and signs of coagulopathy 13.
Histopathology: Predominant vascular lesions include tufted angiomas (TA) and Kaposiform hemangioendotheliomas (KHE), with infantile hemangiomas less common 2.
Laboratory Tests: Platelet count monitoring, coagulation profile 13.Management
First-Line Treatments:
- Corticosteroids: Initial treatment with variable response rates (11.4% response in one study) 3.
- Interferon-Alpha: Effective in cases resistant to other therapies, leading to significant platelet count increase and hemangioma reduction 4.
Adjunctive Treatments:
- Radiation Therapy: Critical in refractory cases, showing improvement in platelet counts and resolution of hemangiomas 1.
- Combined Therapy: Steroids combined with radiation therapy often used when initial treatments fail 3.Special Populations
Pediatrics: Majority of cases diagnosed in infancy with superficial skin hemangiomas; multimodal approaches are essential 3.
Comorbidities: Severe thrombocytopenia and hemangioma extension may preclude surgical intervention, necessitating alternative therapies like interferon 4.Key Recommendations
Initiate corticosteroids as first-line therapy for Kasabach-Merritt syndrome, though response rates may be limited 3 (Evidence: Moderate).
Consider combined corticosteroid and radiation therapy for patients who do not respond adequately to corticosteroids alone 3 (Evidence: Moderate).
Evaluate interferon-alpha therapy for severe, refractory cases where other treatments fail, given its potential for significant clinical improvement 4 (Evidence: Weak).References
1 Leong E, Bydder S. Use of radiotherapy to treat life-threatening Kasabach-Merritt syndrome. Journal of medical imaging and radiation oncology 2009. link
2 Alvarez-Mendoza A, Lourdes TS, Ridaura-Sanz C, Ruiz-Maldonado R. Histopathology of vascular lesions found in Kasabach-Merritt syndrome: review based on 13 cases. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2000. link
3 Shin HY, Ryu KH, Ahn HS. Stepwise multimodal approach in the treatment of Kasabach-Merritt syndrome. Pediatrics international : official journal of the Japan Pediatric Society 2000. link
4 Nako Y, Fukushima N, Igarashi T, Hoshino M, Sugiyama M, Tomomasa T et al.. Successful interferon therapy in a neonate with life-threatening Kasabach-Merritt syndrome. Journal of perinatology : official journal of the California Perinatal Association 1997. link